OBVIA PHARMACEUTICAL Trademark

Trademark Overview

On Friday, April 24, 2020, a trademark application was filed for OBVIA PHARMACEUTICAL with the United States Patent and Trademark Office. The USPTO has given the OBVIA PHARMACEUTICAL trademark a serial number of 88886185. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, November 16, 2022. The OBVIA PHARMACEUTICAL trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical products development
obvia pharmaceutical

General Information

Serial Number88886185
Word MarkOBVIA PHARMACEUTICAL
Filing DateFriday, April 24, 2020
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, November 16, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 13, 2021

Trademark Statements

Disclaimer with Predetermined Text"PHARMACEUTICAL"
Goods and ServicesPharmaceutical products development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, May 6, 2020
Primary Code042
First Use Anywhere DateTuesday, October 1, 2019
First Use In Commerce DateFriday, November 15, 2019

Trademark Owner History

Party NameNOT AVAILABLE
Party Type20 - Owner at Publication
Legal Entity Type01 - Individual
AddressMADISON, WI 53705
Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressMADISON, WI 53705

Trademark Events

Event DateEvent Description
Thursday, November 17, 2022ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Wednesday, November 16, 2022ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Wednesday, November 16, 2022ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, May 4, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, May 4, 2022NON-FINAL ACTION E-MAILED
Wednesday, May 4, 2022SU - NON-FINAL ACTION - WRITTEN
Friday, April 8, 2022STATEMENT OF USE PROCESSING COMPLETE
Thursday, March 3, 2022USE AMENDMENT FILED
Tuesday, March 29, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, March 3, 2022TEAS STATEMENT OF USE RECEIVED
Tuesday, September 7, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 13, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 13, 2021PUBLISHED FOR OPPOSITION
Wednesday, June 23, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, June 7, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 7, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 7, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 7, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, June 4, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, June 4, 2021NON-FINAL ACTION E-MAILED
Friday, June 4, 2021NON-FINAL ACTION WRITTEN
Saturday, May 15, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, May 15, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 12, 2021ASSIGNED TO LIE
Saturday, January 30, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Saturday, January 30, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, January 30, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, January 30, 2021NOTICE OF REVIVAL - E-MAILED
Saturday, January 30, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, January 30, 2021PETITION TO REVIVE-GRANTED
Saturday, January 30, 2021TEAS PETITION TO REVIVE RECEIVED
Friday, January 29, 2021ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Friday, January 29, 2021ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Saturday, July 18, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, July 18, 2020NON-FINAL ACTION E-MAILED
Saturday, July 18, 2020NON-FINAL ACTION WRITTEN
Saturday, July 18, 2020ASSIGNED TO EXAMINER
Wednesday, May 6, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 28, 2020NEW APPLICATION ENTERED

Related Keywords

pharmaceutical obvia development products